SCLC, addressing a high-relapse setting with limited second-line efficacy and modest survival benefit. Ifinatamab deruxtecan ...
Gotistobart reduced risk of death by 54% and doubled 12-month survival vs chemotherapy in advanced squamous NSCLC after prior ...
Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet ...
Trastuzumab pamirtecan, a novel antibody-drug conjugate, showed initial efficacy signals in pretreated patients with ...
PYNNACLE enrolled heavily pretreated TP53 Y220C–mutant ovarian cancer (median four prior lines), including platinum-resistant ...
Detailed price information for Ivanhoe Mines Ltd (IVN-T) from The Globe and Mail including charting and trades.
“Setidegrasib is the first drug in this KRAS degrader class targeting KRAS G12D in solid tumors,” lead investigator Wungki ...
GSK has reported encouraging early clinical data from the global phase I BEHOLD-1 trial of mocertatug rezetecan, a ...
A teacher shared concerns about learners struggling to read and understand English, sparking discussion about deeper ...
An app geared at helping middle and high school students stay focused is sending a Comstock Public School eighth grader to ...
Throughout their program, School of Advanced Military Studies students are challenged to become creative and critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results